Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat

Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat is organized by Rockpointe Corporation.,Release Date: Aug 22, 2022,Expiration Date: Aug 22, 2023,Description:,The incidence of nontuberculous mycobacterial infections caused by Mycobacterium avium complex (NTM-MAC) has increased dramatically in recent decades, while the 5-year survival of patients with NTM-MAC infections remains similar to that of patients with lung cancer. Diagnoses are often delayed due to the nonspecific presentation of NTM-MAC and radiological findings that overlap with other pulmonary diseases. NTM-MAC treatment is also difficult with the use of multiple antibiotic regimens and the frequency of refractory disease. In recent years, the availability of amikacin liposome inhalation suspension (ALIS) has provided another option for patients with NTM-MAC who do not achieve a negative sputum culture after a minimum of six consecutive months of multidrug regimen therapy.,This activity, “Management Strategies for Mycobacterium Avium Complex Infections: Diagnosis and Treatment of a Growing Health Threat” will provide pulmonologists with expert-led discussions of guideline-based diagnosis and treatment of NTM to improve clinician skill in identifying early clinical signs of NTM-MAC, diagnosis, treatment selection, and effective communication with patients regarding NTM-MAC management,Educational Objectives:,At the conclusion of this education, participants should be able to:,• Identify clinical features that raise the suspicion of NTM-MAC infection,• Diagnose NTM-MAC based on current evidence-based diagnostic criteria,• Evaluate the safety and efficacy of current and emerging therapies for NTM-MAC,• Integrate guideline-based NTM-MAC therapies into treatment regimens based on current evidence,• Communicate effectively with patients regarding NTM-MAC treatment selection, expectations of treatment, side effects, monitoring strategies, and treatment adherence